Skip to main content
Equibles
LSTA logo

LSTA · Lisata Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track LSTA — free

Use LSTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LSTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.26 -0.21 (-14.29%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”
View the 10-Q filed Aug 6, 2026
Market Cap
$14.24M
Shares
9.01M
Volume · Oct 5 90.75K Avg daily vol (3M) 286.44K

Lisata Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Lisata Therapeutics, Inc. (LSTA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$37.38M '22 Q3 22-11-10 · $ −$6.19M '23 Q1 23-05-09 · $ −$4.03M '23 Q2 23-08-14 · $ −$5.26M '23 Q3 23-11-02 · $ −$5.37M '23 Q4 24-02-29 · $ −$5.40M '24 Q1 24-06-27 · $ −$5.04M '24 Q2 24-08-12 · $ −$4.93M '24 Q3 24-11-12 · $1.00M −$4.61M '24 Q4 25-02-27 · $ −$4.72M '25 Q1 25-05-08 · $70,000 −$4.66M '25 Q2 25-08-07 LATEST · $ −$4.25M '25 Q3 25-11-06
Earnings call
FY25 · Q3
2025-11-06
Lisata Therapeutics, Inc. (LSTA) Q3 2025 Earnings Call Transcript
Positive tone certepatide clinical development Phase 3 planning and funding business development and licensing
Revenue
$
Diluted EPS
$-0.49
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Lisata Therapeutics, Inc. (LSTA) Q2 2025 Earnings Call Transcript
Positive tone Certepetide clinical development Intellectual property / patents Regulatory interactions and designations
Revenue
$70,000
Diluted EPS
$-0.54
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Call Transcript
Positive tone Certepetide clinical pipeline China partnership with Qilu Tethered delivery / ADC collaboration
Revenue
$
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Lisata Therapeutics, Inc. (LSTA) Q4 2024 Earnings Call
Revenue
$1.00M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript
Positive tone Certepetide clinical development ASCEND trial in mPDAC Partnered / investigator-sponsored collaborations
Revenue
$
Diluted EPS
$-0.59
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Lisata Therapeutics, Inc. (LSTA) Q2 2024 Earnings Call Transcript
Positive tone Certepetide clinical pipeline advancement Clinical trial enrollment and progress Geographic site and operational updates
Revenue
$
Diluted EPS
$-0.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-06-27
Lisata Therapeutics, Inc. (LSTA) Q1 2024 Earnings Call Transcript
Confident tone Lead candidate certepetide (LSTA1) development Phase 2a BOLSTER trial Manufacturing cost and pharmacoeconomics
Revenue
$
Diluted EPS
$-0.65
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Lisata Therapeutics, Inc. (LSTA) Q4 2023 Earnings Call Transcript
Positive tone LSTA1 lead candidate Qilu partnership and milestones Clinical pipeline progress
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Lisata Therapeutics, Inc. (LSTA) Q3 2023 Earnings Call Transcript
Revenue
$
Diluted EPS
$-0.65
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Lisata Therapeutics, Inc. (LSTA) Q2 2023 Earnings Call Transcript
Revenue
$
Diluted EPS
$-0.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Lisata Therapeutics, Inc. (LSTA) Q1 2023 Earnings Call Transcript
Revenue
$
Diluted EPS
$-0.77
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Lisata Therapeutics, Inc. (LSTA) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Lisata Therapeutics, Inc. (LSTA) Q3 2022 Earnings Call Transcript
Revenue
$
Diluted EPS
$-7.88
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-05
Lisata Therapeutics, Inc. (LSTA) Q2 2022 Earnings Call Transcript
Diluted EPS
$-1.64
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Lisata Therapeutics, Inc. (LSTA) Q1 2022 Earnings Call Transcript
Diluted EPS
$-1.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-22
Lisata Therapeutics, Inc. (LSTA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Lisata Therapeutics, Inc. (LSTA) Q3 2021 Earnings Call Transcript
Diluted EPS
$-1.74
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Lisata Therapeutics, Inc. (LSTA) Q2 2021 Earnings Call Transcript
Diluted EPS
$-1.50
▼ 120% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Lisata Therapeutics, Inc. (LSTA) Q1 2021 Earnings Call Transcript
Diluted EPS
$-2.85
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Lisata Therapeutics, Inc. (LSTA) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Lisata Therapeutics, Inc. (LSTA) Q3 2020 Earnings Call Transcript
Diluted EPS
$-4.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
Lisata Therapeutics, Inc. (LSTA) Q2 2020 Earnings Call Transcript
Diluted EPS
$7.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Lisata Therapeutics, Inc. (LSTA) Q1 2020 Earnings Call Transcript
Diluted EPS
$-5.70
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Lisata Therapeutics, Inc. (LSTA) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 webcasts
Key facts CIK 320017 CUSIP 128058302 13F (30d) 2 filings 2 filers Visit website Investor relations